108 related articles for article (PubMed ID: 10201922)
1. Administration of an IL-12-encoding DNA plasmid prevents the development of chronic graft-versus-host disease (GVHD).
Okubo T; Hagiwara E; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Aoki I; Okuda K; Miyazaki J; Ishigatsubo Y
J Immunol; 1999 Apr; 162(7):4013-7. PubMed ID: 10201922
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
Williamson E; Garside P; Bradley JA; More IA; Mowat AM
J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
[TBL] [Abstract][Full Text] [Related]
3. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
[TBL] [Abstract][Full Text] [Related]
4. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
Via CS; Rus V; Gately MK; Finkelman FD
J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
[TBL] [Abstract][Full Text] [Related]
5. IL-12 is a central mediator of acute graft-versus-host disease in mice.
Williamson E; Garside P; Bradley JA; Mowat AM
J Immunol; 1996 Jul; 157(2):689-99. PubMed ID: 8752918
[TBL] [Abstract][Full Text] [Related]
6. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
7. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-12 encoding plasmid administration on tight-skin mouse.
Tsuji-Yamada J; Nakazawa M; Takahashi K; Iijima K; Hattori S; Okuda K; Minami M; Ikezawa Z; Sasaki T
Biochem Biophys Res Commun; 2001 Jan; 280(3):707-12. PubMed ID: 11162578
[TBL] [Abstract][Full Text] [Related]
9. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
10. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
Allen RD; Staley TA; Sidman CL
Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
[TBL] [Abstract][Full Text] [Related]
11. H1521, a novel derivative of 4-hydroxyquinoline-3-carboxamide, suppresses the development of lupus in mice by inducing Th1 cytokine profile in T cells.
Xiao ZY; Chen SH; Zhou WX; Zhang YX; Cheng JP; Yang RF
Int Immunopharmacol; 2011 Apr; 11(4):435-43. PubMed ID: 21195814
[TBL] [Abstract][Full Text] [Related]
12. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis.
Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA
J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243
[TBL] [Abstract][Full Text] [Related]
13. A locus closely linked to Mtv7 on mouse chromosome 1 influences development of acute versus chronic graft-versus-host disease in a murine model.
Allen RD; Slayback DL; Harper JM; Aguirre TL; Dobkins JA
Clin Immunol; 2000 Apr; 95(1 Pt 1):9-19. PubMed ID: 10794427
[TBL] [Abstract][Full Text] [Related]
14. The nephritogenic T cell response in murine chronic graft-versus-host disease.
Meyers CM; Tomaszewski JE; Glass JD; Chen CW
J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
[TBL] [Abstract][Full Text] [Related]
15. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
Fast LD
J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
[TBL] [Abstract][Full Text] [Related]
16. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
[TBL] [Abstract][Full Text] [Related]
17. Association between leukocyte infiltration and development of glomerulosclerosis in experimental lupus nephritis.
Kootstra CJ; Sutmuller M; Baelde HJ; de Heer E; Bruijn JA
J Pathol; 1998 Feb; 184(2):219-25. PubMed ID: 9602715
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
Portanova JP; Claman HN; Kotzin BL
J Immunol; 1985 Dec; 135(6):3850-6. PubMed ID: 3877758
[TBL] [Abstract][Full Text] [Related]
20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]